Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 14, 2026; 32(46): 123234
Published online Dec 14, 2026. doi: 10.3748/wjg.123234
Published online Dec 14, 2026. doi: 10.3748/wjg.123234
Table 2 Summary of multi-level clinical interventions for intestinal failure in critically ill patients
| Intervention level | Primary strategy | Key measures | Primary clinical outcomes | Effect size/results | Ref. |
| Microbiota | ASP | Optimize selection, shorten courses, reduce broad-spectrum coverage | Broad-spectrum antibiotic use rate, AGI incidence | Use rate ↓ 20%-30%; AGI incidence ↓ 15%-25% | [37] |
| Microbiota | Microbial reconstitution (probiotics/synbiotics) | Probiotic/synbiotic supplementation | Antibiotic-associated diarrhea incidence | RR = 0.70-0.80 | [49] |
| Microbiota | Microbial reconstitution (FMT) | FMT | CDAD success rate, 30-day mortality | Success rate 80%-90%; mortality significantly reduced | [42,43] |
| Metabolic | Nutritional support and SCFA restoration | Fiber-enriched enteral nutrition | AGI severity, butyrate-producing bacteria abundance | OR = 0.82-0.86 | [46] |
| Metabolic/barrier | Early enteral nutrition | Initiated within 48 hours | Bloodstream infection rate, ICU length of stay | OR = 0.73 (95%CI: 0.57-0.93) | [52] |
| Barrier | Barrier protection | Glutamine supplementation | Intestinal permeability | Improved in high-dose, short-course subgroup; no significant benefit otherwise | [55] |
| Inflammatory | Immunomodulation and anti-inflammatory therapy | Low-dose corticosteroids, etc | Mortality in sepsis | RR = 0.87 (95%CI: 0.81-0.93) | [56] |
| Systemic | Organ support (high-quality evidence) | Hemodynamic management, mechanical ventilation | Short-term prognosis, acute-phase mortality | Standardized implementation improves short-term outcomes; does not address upstream dysbiosis | [57] |
| Systemic | CRRT (moderate-quality evidence) | Continuous renal replacement therapy | Cytokine clearance, fluid balance | Some attenuation of circulating mediators; effect on gut microbiota unproven | [57] |
- Citation: Tian L, Xu SS. Antibiotic-associated gut dysbiosis and intestinal failure in critically ill patients: Mechanisms and interventions. World J Gastroenterol 2026; 32(46): 123234
- URL: https://www.wjgnet.com/1007-9327/full/v32/i46/123234.htm
- DOI: https://dx.doi.org/10.3748/wjg.123234